C. Karner

发表

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

P. Poole, Jimmy Chong, C. Karner, 2012, The Cochrane database of systematic reviews.

Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation.

C. Karner, S. Edwards, N. Trevor, 2015, Health technology assessment.

Induction of angiogenesis by airway smooth muscle from patients with asthma.

B. O'connor, C. Karner, Tak H. Lee, 2008, American journal of respiratory and critical care medicine.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

S. Spencer, C. Cates, C. Karner, 2011, The Cochrane database of systematic reviews.

Clinical importance cannot be ruled out using mean difference alone

C. Cates, C. Karner, 2015, BMJ : British Medical Journal.

Diagnostic accuracy of reflectance confocal microscopy using VivaScope for detecting and monitoring skin lesions: a systematic review

C. Karner, R. Patalay, S. Edwards, 2017, Clinical and experimental dermatology.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kayleigh Kew, C. Karner, G. Ferrara, 2013, The Cochrane database of systematic reviews.

Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.

C. Cates, C. Karner, C. Cates, 2011, The Cochrane database of systematic reviews.

Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.

C. Cates, C. Karner, 2013, The Cochrane database of systematic reviews.

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.

C. Cates, C. Karner, 2012, The Cochrane database of systematic reviews.

Long-acting beta2-agonists for chronic obstructive pulmonary disease

C. Karner, E. Stovold, 2012 .

Heparin and structurally related polymers attenuate eotaxin‐1 (CCL11) release from human airway smooth muscle

B. O'connor, C. Karner, C. Page, 2008, British journal of pharmacology.

Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma

Sun Ying, Charlotta Karner, C. G. McVicker, 2009, Proceedings of the National Academy of Sciences.

Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

C. Karner, S. Barton, S. Edwards, 2016, Health technology assessment.

Mirabegron for the treatment of symptoms associated with overactive bladder

C. Karner, S. Edwards, 2013 .

VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation.

C. Karner, I. Mavranezouli, S. Edwards, 2016, Health technology assessment.

Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

C. Karner, S. Barton, S. Edwards, 2021, Health technology assessment.

Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review.

D. Baldwin, C. Karner, S. Barton, 2014, Health technology assessment.

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

C. Cates, C. Karner, 2011, The Cochrane database of systematic reviews.

Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.

C. Karner, R. Dennis, M. Rojas-Reyes, 2016, The Cochrane database of systematic reviews.

Tiotropium versus placebo for chronic obstructive pulmonary disease.

P. Poole, Jimmy Chong, C. Karner, 2014, The Cochrane database of systematic reviews.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

S. Spencer, C. Cates, C. Karner, 2011, The Cochrane database of systematic reviews.

Ion channel regulation of intracellular calcium and airway smooth muscle function.

M. Sanderson, C. Karner, S. Ito, 2009, Pulmonary pharmacology & therapeutics.

Primary care based clinics for asthma.

C. Karner, Elora Baishnab, 2012, The Cochrane database of systematic reviews.

Tiotropium versus placebo for chronic obstructive pulmonary disease.

P. Poole, Jimmy Chong, C. Karner, 2012, The Cochrane database of systematic reviews.

Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)

C. Karner, L. Nherera, N. Trevor, 2013 .

Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.

Kayleigh Kew, C. Karner, S. Edwards, 2018, Health technology assessment.

Targeted therapies for previously treated advanced or metastatic renal cell carcinoma: systematic review and network meta-analysis

Kayleigh Kew, C. Karner, S. Edwards, 2019, BMJ Open.

Cochrane Airways Group reviews were prioritized for updating using a pragmatic approach.

C. Karner, E. Welsh, C. Cates, 2015, Journal of clinical epidemiology.

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

C. Cates, C. Karner, 2011, The Cochrane database of systematic reviews.

Primary care based clinics for asthma.

C. Karner, Elora Baishnab, 2012, Cochrane Database of Systematic Reviews.

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.

C. Karner, G. Marceniuk, T. Jhita, 2024, Health technology assessment.